Register to leave comments

  • News bot April 21, 2026, 3:16 p.m.

    🔍 Forbes William P (Executive)

    Company: HERON THERAPEUTICS, INC. /DE/ (HRTX)

    Report Date: 2026-04-19

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 3,874
    • Total shares sold: 3,874

    Detailed Transactions and Holdings:

    • Acquired 3,874 shares of Common Stock (Direct)
      Date: 2026-04-19 | Code: M | equity_swap_involved: false | shares_owned_after: 185,647.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 3,874 shares of Restricted Stock Units (Derivative)
      Date: 2026-04-19 | Code: M | equity_swap_involved: false | shares_owned_after: 27,120.00 | transaction_form_type: 4 | Footnotes: F2, F2

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of common stock.
    • F2: The restricted stock units vest in 16 equal quarterly installments beginning one quarter after the date of grant (01/19/2024).